Market Indices
Latest News
 |
| ||
| ||
|
Price Targets
Lincoln Kong from Goldman Sachs issued a price target of $161.00 for NTES on 2025-09-15 19:30:18.The adjusted price target was set to $161.00.At the time of the announcement,
September 15, 2025 NTES 1.40%
Jason Helfstein from Mizuho Securities issued a price target of $159.00 for BABA on 2025-09-02 11:00:00.The adjusted price target was set to $159.00.At the time of the announcement,
September 2, 2025 BABA 2.48%
Thomas Chong from Jefferies issued a price target of $165.00 for BABA on 2025-08-29 19:24:47.The adjusted price target was set to $165.00.At the time of the announcement, BABA...
September 1, 2025 BABA 2.48%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| SQNS Sequans Communications S. | 9.56
895.31% | ||||||||||||||||||
| ADXN Addex Therapeutics Ltd | 10.85
15.92% | ||||||||||||||||||
| VALN Valneva SE | 10.00
12.60% | ||||||||||||||||||
| RDHL RedHill Biopharma Ltd. | 1.70
11.77% | ||||||||||||||||||
| YQ 17 Education & Technology | 3.45
11.65% | ||||||||||||||||||
| BIDU Baidu, Inc. | 137.85
11.36% | ||||||||||||||||||
| XNET Xunlei Limited | 8.13
11.22% | ||||||||||||||||||
| FEDU Four Seasons Education (C | 14.75
9.79% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 0.22%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA -1.45%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 CUK 0.14%